… Calamia, MD, Associate Professor of Medicine, Mayo Clinic, 4500 San Pablo Road,
Jacksonville, FL 32225, USA Tel: +1 904 953 2062; fax: +1 904 953 0665; e-mail: [email …

Localized deposition of amyloid may occur in individual organs, in the absence of systemic
involvement. The reason for localized deposition is unknown, but it is hypothesized that …

Because of earlier recognition, aggressive medical treatment, and novel surgical procedures,
the morbidity and mortality of large vessel vasculitis in Behçet disease are beginning to …

Objective Behçet's disease ( BD ) is a chronic, relapsing, inflammatory vascular disease with
no pathognomonic test. Low sensitivity of the currently applied International Study Group ( …

Objective To analyze the clinical findings, response to therapy, outcome, and incidence of
primary central nervous system vasculitis (PCNSV) in a large cohort from a single center …

Objective Glucocorticoid (GC) therapy for giant cell arteritis (GCA) is effective but requires
prolonged administration, resulting in adverse side effects. The goal of the current study was to …

Objective Behçet's disease (BD) is a rare, multisystem inflammatory disorder of unknown
cause. Although well‐documented in Eastern populations, epidemiologic data is scarce in …

Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study | NEJM Skip to
main content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare …

A retrospective study of the histories of 100 patients with biopsy‐proven giant cell arteritis
was performed. Fifteen of these patients had “fever of unknown origin” as the initial …

Objectives: Review the clinical and physiopathologic aspects of the Churg-Strauss syndrome
(CSS), including recent data regarding treatment and possible etiologic and triggering …